M

Complementary Medicine

Home  >  Complementary Medicine

The Yes to Life Show – Nov 2022

Please visit the Yes To Life website to listen to the program. 50 years and counting Show #385 - Date: 11 Nov 2022 Ralph Moss has an interesting talk with The Yes To Life show host, Robin Daly....

Guide to Food and Cancer

The Moss Method™ – Guide to Food and Cancer

It's Contentious No area of research is as contentious as the relationship between food, drink or activity and the risk of cancer. Also, there are literally tens of thousands of articles in the...

What Keeps Me Working?

Hope!! I am writing this at five in the morning. For years, this has been the hour I get to my office and begin my work. I am armed with my computers, phone, files, and several walls of books,...

Am I a Soft-Core Quackbuster?

An Interesting Letter I received a very interesting email from a reader, who wrote: “It seems like you are skeptical of most alternative treatments due to the lack of publishing in scientific...

About Ralph W. Moss, PhD

Ralph Moss is considered one of the foremost authorities in the world on complementary, integrative and alternative cancer treatments. Since 1974 he has written 12 books and three films about...

Is Laetrile Really Vitamin B17?

Crucial Facts "Laetrile's history has been complex, tortuous, kaleidoscopic. Begin­ning inauspiciously like hundreds of other small-time anticancer schemes, Laetrile soared to a notorious...

Down Goes Dr. Baselga

Sandpiper Trial On Saturday, June 2, 2018, Dr. José Baselga, MD, Physician-in-chief of Memorial Sloan-Kettering Cancer Center was enthused about the results of the SANDPIPER trial. He told the...

Keytruda: Toxic, Expensive and Not So Effective

Best Selling Cancer Drug in 2019 Keytruda® (pembrolizumab) is toxic, expensive, and not as effective as one would wish. But at $7.2 billion, it was the best-selling cancer drug in 2019. At the...

Imatinib (Gleevec) for Chronic Myeloid Leukemia

Glee Over GleevecAfter the announcement of herceptin, work accelerated on many other targeted agents for cancers. In that same year, clinical trials began for a new drug for chronic myeloid...

FDA Reverses Approval of Avastin

Stunning Reversal In a stunning rebuke to the former director of the Food and Drug Administration (FDA), an advisory panel has recommended removing the approval of the drug Avastin (bevacizumab)...

The Disturbing Case of José Baselga

Conflict of InterestThe best-publicized case of conflict of interest in cancer involved José Baselga, MD, Ph.D., the Physician-in-Chief, i.e., the top doctor of Memorial Sloan-Kettering Cancer...

Selumetinib: The Selling of a Drug

Targeted Therapies    I attended the 2013 annual meeting of the American Society of Clinical Oncology (ASCO). Some of my journalistic colleagues there were excited about the latest findings...

The Amazing Case of Dr Wortman

Precision Medicine Let's start with Precision Medicine at its very best. This was the inspiring story of Dr. Lukas Wortman, MD, which helped catapult the topic into public consciousness. In 2012,...

Red Wine and Breast Cancer

Resveratrol, A Natural Compound Found in the Skin Of GrapesMost of my research involves long hours on the computer or in the medical library. So it was a pleasure to do fieldwork in New York’s...

Shadows Fall on Anti-Angiogenic Drugs

The Main Hope of Conventional OncologyFor the past dozen years, drugs that inhibit the growth of new blood vessels—a strategy called anti-angiogenesis—have been the main hope of conventional...

The Goal of a New Drug

Help Cure the Patient of CancerFirst, we must clarify the goal of any new cancer therapy. Most people would say that the goal is to help cure the patient of cancer. But a long time ago, Memorial...

FDA and FBI Raid Oklahoma Laetrile Clinic

The Camelot ClinicOn Tuesday, April 23, 2013, agents of the Food and Drug Administration (FDA), the Federal Bureau of Investigation (FBI), and the Oklahoma Medical Board raided an alternative...

Kombucha Benefits are Cloudy

A Fermented Drink I hadn’t thought about drinking kombucha tea until I saw a row of brightly colored glass bottles on a shelf in my local supermarket. For the uninitiated, kombucha is a fermented...

What Are Surrogate Endpoints?

Progression Free SurvivalThe NCI Dictionary of Cancer Terms defines a surrogate endpoint in clinical trials as: “...an indicator or sign used in place of another to tell if a treatment works....

Is Chemotherapy Toxic?

Considering Toxicity Let us consider the question of toxicity, which we discussed in articles on specific trials of so-called “Precision Medicine’ for cancer. When targeted therapy was first...

The Strange Case of Xalkori

A Great Success Story?Let us look at a drug that is considered one of the great success stories of the precision medicine approach, Xalkori (crizotinib). The story of Xalkori illustrates some of...

The Case of Xalkori (crizotinib)

Conflicts of InterestAlmost every study of a new cancer drug is riddled with conflicts of interest. Let us focus on one of these drugs, crizotinib (Xalkori®). But we could conduct the same sort...

Vitamins and Chemotherapy

Few issues create more friction between mainstream oncologists and advocates of complementary medicine than the role of vitamins during chemotherapy. While many researchers consider their use...

The Pitfalls of Progression-Free Survival (PFS)

A Hypothetical LookLet us consider the pitfalls of using progression-free survival (PFS) as a “surrogate endpoint” by showing how someone could extend patients’ PFS, without actually helping them...

Green Tea as an Immune Checkpoint Inhibitor

Value in Prevention and Treatment One of the most exciting developments in cancer in the past 30 years has been a treatment strategy known as immune checkpoint blockade. ICB relies on a...

Cancer Treatment on a Tight Budget

Anticancer Strategies on a Tight Budget Are you looking for an Anti-Cancer Plan on a tight budget? I was once asked to devise a plan for a U.S. Army veteran who was living on a pension and could...

Biases in Clinical Trials

Assessing the Effects of a New DrugThere are various ways in which the sponsors of a clinical trial can exaggerate the effects of a new drug on progression-free survival (PFS). This can be done...